| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4167121 | The Journal of Pediatrics | 2011 | 7 Pages |
Abstract
In our retrospective study, patients with IVIG-resistant Kawasaki disease whose first re-treatment was with infliximab, compared with IVIG, had faster resolution of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar; the power of the study was limited.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Mary Beth MD, Kimberlee ScD, Jane C. MD, Elena MD, Adriana H. MD, MAS, Virginia E. MD, Annette RN, MSN, PNP, David R. MD, Robert P. MD, Jane W. MD, MPH,